Tesamorelin is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH), engineered with a trans-3-hexenoic acid modification for enhanced enzymatic stability. It has been studied for its ability to stimulate pulsatile growth hormone release, and its effects on IGF-1, visceral fat, and body composition.
Available in 10mg | Lyophilised powder | ≥99% purity
£64.99
6 in stock
More Peptides makes no therapeutic, pharmacological, or health-related claims in respect
of this or any other product. Any references to scientific literature are provided for informational purposes only.
This product must be stored in accordance with the conditions stated on the label.
More Peptides accepts no liability for misuse or use outside the stated research purpose.
Tesamorelin is a 44-amino acid synthetic analogue of Growth Hormone-Releasing Hormone (GHRH), modified at its N-terminus with a trans-3-hexenoic acid group to improve resistance to enzymatic degradation while retaining full biological activity.
Its mechanism of action involves binding to GHRH receptors on the anterior pituitary gland, stimulating the natural, pulsatile release of growth hormone. This subsequently influences IGF-1 and IGFBP-3 levels, with downstream effects on lipid metabolism, visceral fat, and body composition. It is one of the most thoroughly characterised GHRH analogues in research literature. Supplied at ≥99% purity, HPLC verified. Intended strictly for research and laboratory use only.
Key Attributes
